Aortic Aneurysms
W. L. Gore & Associates Enrolls First Patient in Study of 45 mm GORE TAG Thoracic Endoprosthesis
Published in Medical Letter on the CDC and FDA, March 11th, 2007
W. L. Gore & Associates (Gore) announced that the first patient has been enrolled in a U.S. Food and Drug Administration (FDA) approved IDE study for the 45 mm* GORE TAG(R) Thoracic Endoprosthesis for treatment of aneurysms of the descending thoracic aorta. Grayson Wheatley, MD, Arizona Heart Institute, enrolled the first patient in the multi-center clinical study, which will assess the safety and efficacy of the 45 mm GORE TAG Device for the primary treatment in patients with aortic inner diameters adjacent to the aneurysm ranging from 37 to 42 mm.
"We're pleased to have initiated this study by enrolling the first patient," said Dr. Wheatley. "The procedure went very...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Addiction Medicine
Catalyst Pharmaceutical Partners, Inc. Strengthens Scientific Advisory Board With Appointment of Richard A. Rawson, Ph.D. - Adverse Drug Reactions
New Version of Devices to Treat Clogged Neck Arteries Approved by U.S. Food and Drug Administration - Analgesics
Elite Pharmaceuticals Provides Positive Clinical Update - Anthrax
FDA Grants Fast Track Designation to Emergent BioSolutions' BioThrax for Post-Exposure Prophylaxis against Anthrax Infection - Anthrax Vaccines
Emergent BioSolutions Remains Committed to Development of Enhanced Anthrax Countermeasures - Antisense Technology
Genta Incorporated Announces Fourth Quarter and Year End 2006 Financial Results and Corporate Highlights - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
